Literature DB >> 3040799

Subclass restriction of human enterovirus antibodies.

E G Torfason, C B Reimer, H L Keyserling.   

Abstract

We studied antibodies to enteroviruses in four groups of serum specimens: those from healthy adults, cord blood specimens, serum specimens known to contain immunoglobulin M (IgM) to coxsackie B (CB) viruses by radioimmunoassay, and serum specimens from children with symptomatic enteroviral infections. Enzyme-linked immunosorbent assays (ELISAs) were developed to detect the IgG class- and subclass (IgG1, IgG2, IgG3, and IgG4)-specific responses to CB3. The CB3 virus ELISA was not type specific. There was very poor correlation between CB3 virus neutralizing titer and IgG anti-CB3 virus ELISA results, indicating that antibodies to heterologous picornaviruses cross-react with CB3 virus in the assay. All serum specimens tested except one were IgG positive for CB3 virus. All 32 cord serum specimens were positive for IgG1 and IgG3. No enterovirus-specific IgG2 or IgG4 was detected in any serum specimen tested. Most serum specimens from the IgM-positive group, healthy adults, and children with enterovirus infections were positive for IgG1 and IgG3. Class and subclass antibody titers remained constant over time. IgG antibodies to enteroviruses appear to be restricted to the IgG1 and IgG3 subclasses. This pattern is similar to results obtained by other investigators evaluating IgG subclass antibodies to protein antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040799      PMCID: PMC269228          DOI: 10.1128/jcm.25.8.1376-1379.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Detection of IgG-associated determinants in reduced and alkylated preparations of human IgG3 by monoclonal antibodies.

Authors:  A M Brown; M L Dumas; C B Reimer; R E Louie; R C Harmon
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

2.  Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes.

Authors:  C B Reimer; D J Phillips; C H Aloisio; D D Moore; G G Galland; T W Wells; C M Black; J S McDougal
Journal:  Hybridoma       Date:  1984

3.  Heterotypic reactions in a radioimmunoassay for coxsackie B virus specific IgM.

Authors:  S F Pugh
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

4.  Characterization of the subclasses and light chain types of IgG antibodies to rubella.

Authors:  F Skvaril; U Schilt
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

5.  Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

Authors:  J E Banatvala; J Bryant; G Schernthaner; M Borkenstein; E Schober; D Brown; L M De Silva; M A Menser; M Silink
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

6.  IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.

Authors:  R L Rubin; F L Tang; A H Lucas; H L Spiegelberg; E M Tan
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

7.  Monoclonal antibody-based solid-phase immunoenzymometric assays for quantifying human immunoglobulin G and its subclasses in serum.

Authors:  C Papadea; I J Check; C B Reimer
Journal:  Clin Chem       Date:  1985-12       Impact factor: 8.327

8.  Indirect and reverse radioimmunoassays and their apparent specificities in the detection of antibodies to enteroviruses in human sera.

Authors:  E G Torfason; G Frisk; H Diderholm
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

9.  Reverse radioimmunoassays of IgM and IgG antibodies to Coxsackie B viruses in patients with acute myopericarditis.

Authors:  G Frisk; E G Torfason; H Diderholm
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity.

Authors:  G Frisk; J Fohlman; M Kobbah; U Ewald; T Tuvemo; H Diderholm; G Friman
Journal:  J Med Virol       Date:  1985-11       Impact factor: 2.327

View more
  2 in total

1.  Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.

Authors:  P Bostik; J Winter; T G Ksiazek; P E Rollin; F Villinger; S R Zaki; C J Peters; A A Ansari
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

2.  Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection.

Authors:  J Huskinson; P N Stepick-Biek; F G Araujo; P Thulliez; Y Suzuki; J S Remington
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.